Related Experiment Video
Updated: Aug 11, 2025

09:53
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
7.3K
NeuroPpred-SVM: A New Model for Predicting Neuropeptides Based on Embeddings of BERT
Yufeng Liu1, Shuyu Wang1, Xiang Li1
1School of Sciences, Anhui Agricultural University, Hefei, Anhui 230036, China.
Journal of Proteome Research
|February 7, 2023
Summary
We developed NeuroPpred-SVM, a novel tool for identifying neuropeptides. This accurate and efficient model outperforms existing methods, aiding in understanding physiological processes and neurological disease treatment.
Area of Science:
- Biochemistry
- Bioinformatics
- Computational Biology
Background:
- Neuropeptides are crucial in physiological functions and disease pathogenesis.
- Accurate neuropeptide identification aids in understanding disease mechanisms and developing treatments for neurological disorders.
- Existing neuropeptide predictors, while effective, can be complex and computationally intensive.
Purpose of the Study:
- To develop a novel, efficient, and accurate neuropeptide prediction model.
- To leverage Bidirectional Encoder Representations from Transformers (BERT) embeddings and sequential features.
- To utilize a Support Vector Machine (SVM) classifier for improved prediction.
Main Methods:
- Proposed NeuroPpred-SVM, integrating BERT embeddings and other sequential features.
- Employed a Support Vector Machine (SVM) classifier for neuropeptide prediction.
- Validated the model using cross-validation and an independent test set.
Main Results:
- Achieved a high cross-validation Area Under the Receiver Operating Characteristic (AUROC) curve of 0.969.
- Attained an AUROC of 0.966 on the independent test set.
- Outperformed four state-of-the-art models in AUROC, Matthews correlation coefficient, accuracy, and specificity.
Conclusions:
- NeuroPpred-SVM demonstrates superior performance in neuropeptide identification.
- The model offers a highly accurate and cost-effective tool for neuropeptide discovery.
- This advancement facilitates research into neuropeptide functions and neurological disease mechanisms.

